Article Details

BridgeBio sends rare disease drugs to new company - Yahoo Finance

Retrieved on: 2024-08-21 16:48:18

Tags for this article:

Click the tags to see associated articles and topics

BridgeBio sends rare disease drugs to new company - Yahoo Finance. View article details on hiswai:

Summary

BridgeBio Pharma's establishment of GondolaBio, funded by top life sciences investors, demonstrates the biopharma sector's strategy of focusing on niche, rare disease treatments, paralleling earlier spinouts like the KRAS-targeted BridgeBio Oncology Therapeutics.

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up